Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings

Benzinga

16 Jun

Beyond Air, Inc. (NASDAQ:XAIR) will release its fourth-quarter financial results after the closing bell on Tuesday, June 17.

Analysts expect the Garden City, New York-based company to report quarterly revenue of $1.39 million, compared to $470,000 a year earlier, according to data from Benzinga Pro.

On April 21, Beyond Air announced its NeuroNOS subsidiary was granted an FDA Orphan Drug Designation.

Beyond Air shares fell 3% to close at $0.1779 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

BTIG analyst Marie Thibault downgraded the stock from Buy to Neutral on June 25, 2024. This analyst has an accuracy rate of 63%.
Truist Securities analyst Gregory Fraser maintained a Buy rating and lowered the price target from $10 to $8 on April 30, 2024. This analyst has an accuracy rate of 63%.

Considering buying XAIR stock? Here’s what analysts think:

Read This Next:

Top 2 Energy Stocks That May Fall Off A Cliff in June

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2543671439"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2543671439\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2543671439?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-16 19:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2543671439","market":"us","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a>, Inc.</strong> (NASDAQ:XAIR) will release its fourth-quarter financial results after the closing bell on Tuesday, June 17.</p>\n<p>Analysts expect the <a href=\"https://laohu8.com/S/GCCO\">Garden City</a>, New York-based company to report quarterly revenue of $1.39 million, compared to $470,000 a year earlier, according to data from Benzinga Pro.</p>\n<p><a href=\"https://laohu8.com/S/ONON\">On</a> April 21, Beyond Air announced its NeuroNOS subsidiary was granted an FDA Orphan Drug Designation.</p>\n<p>Beyond Air shares fell 3% to close at $0.1779 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>BTIG analyst Marie Thibault downgraded the stock from Buy to Neutral on June 25, 2024. This analyst has an accuracy rate of 63%.</li>\n<li>Truist Securities analyst Gregory Fraser maintained a Buy rating and lowered the price target from $10 to $8 on April 30, 2024. This analyst has an accuracy rate of 63%.</li>\n</ul>\n<p>Considering buying XAIR stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"611\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-1024x611.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-1024x611.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-768x458.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233.png 1110w\" width=\"1024\"/></figure>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Energy Stocks That May Fall Off A Cliff in June</strong> </li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-06-16 19:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a>, Inc.</strong> (NASDAQ:XAIR) will release its fourth-quarter financial results after the closing bell on Tuesday, June 17.</p>\n<p>Analysts expect the <a href=\"https://laohu8.com/S/GCCO\">Garden City</a>, New York-based company to report quarterly revenue of $1.39 million, compared to $470,000 a year earlier, according to data from Benzinga Pro.</p>\n<p><a href=\"https://laohu8.com/S/ONON\">On</a> April 21, Beyond Air announced its NeuroNOS subsidiary was granted an FDA Orphan Drug Designation.</p>\n<p>Beyond Air shares fell 3% to close at $0.1779 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>BTIG analyst Marie Thibault downgraded the stock from Buy to Neutral on June 25, 2024. This analyst has an accuracy rate of 63%.</li>\n<li>Truist Securities analyst Gregory Fraser maintained a Buy rating and lowered the price target from $10 to $8 on April 30, 2024. This analyst has an accuracy rate of 63%.</li>\n</ul>\n<p>Considering buying XAIR stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"611\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-1024x611.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-1024x611.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233-768x458.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16071841/image-233.png 1110w\" width=\"1024\"/></figure>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Energy Stocks That May Fall Off A Cliff in June</strong> </li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XAIR","symbol_name":"BEYOND AIR INC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/termination/25/06/45945852/top-wall-street-forecasters-revamp-beyond-air-expectations-ahead-of-q4-earnings","article_id":"2543671439","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2543671439","pubTimestamp":1750072857,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"XAIR":"BEYOND AIR INC"},"translate_title":"华尔街顶级预测者在第四季度财报公布前进行了超出预期的调整","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAIR":0.9},"content_text":"Beyond Air, Inc. (NASDAQ:XAIR) will release its fourth-quarter financial results after the closing bell on Tuesday, June 17.\nAnalysts expect the Garden City, New York-based company to report quarterly revenue of $1.39 million, compared to $470,000 a year earlier, according to data from Benzinga Pro.\nOn April 21, Beyond Air announced its NeuroNOS subsidiary was granted an FDA Orphan Drug Designation.\nBeyond Air shares fell 3% to close at $0.1779 on Friday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nBTIG analyst Marie Thibault downgraded the stock from Buy to Neutral on June 25, 2024. This analyst has an accuracy rate of 63%.\nTruist Securities analyst Gregory Fraser maintained a Buy rating and lowered the price target from $10 to $8 on April 30, 2024. This analyst has an accuracy rate of 63%.\n\nConsidering buying XAIR stock? Here’s what analysts think: \n\nRead This Next:\n\n Top 2 Energy Stocks That May Fall Off A Cliff in June \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}